KBR heads into its July 29 earnings report with a notable insider buying cluster sitting beneath the stock and a short position that has been quietly rebuilding over the past month.
The most compelling data point this week is what happened in mid-May. When KBR broke below $32, insiders stepped in. The CFO Shad Evans bought 8,375 shares at $30.60. A director added 14,500 shares at $32.47. Another director, Lou Von Thaer, picked up 3,000 shares at $30.77. A fourth director added 4,000 shares at $31.44. Net insider activity over the past 90 days totals a purchase of roughly 64,000 shares for around $2.4 million in aggregate value. That cluster came as the stock was near what appears to be a multi-month low. KBR has since rebounded — up 6.2% on the week to $36.67 — and the buyers are now sitting on a meaningful mark-to-market gain.
Short positioning tells a more cautious story, however. SI has climbed around 9.3% over the past month to 5.4% of free float, reaching roughly 6.8 million shares. That is a meaningful drift higher, even though it remains well below the panic levels that trigger serious squeeze dynamics. Critically, the borrow market is extremely relaxed — availability is running at approximately 1,581%, meaning there are more than fifteen shares available to borrow for every share currently shorted. Cost to borrow is just 0.46%, down slightly on the week. The lending market imposes no friction on shorts at all. Options positioning is broadly neutral: the put/call ratio at 0.95 is barely above its 20-day average of 0.93, and the z-score of 0.34 points to no unusual hedging activity in either direction.
The Street broadly retained constructive ratings through the recent weakness, though targets have been drifting steadily lower. Since last November, analysts from Citigroup, UBS, Wells Fargo, BofA, and Truist have all trimmed price targets — the mean now sitting at roughly $47.88, implying around 30% upside from current levels. Citigroup maintained its Buy through the May turbulence, reducing its target to $50 from $53. UBS moved its target down to $36 — almost exactly where KBR trades now — while keeping a Neutral. The bull case centres on backlog visibility (roughly 85% of projected sales already locked in) and the sustainable technology segment. Bears flag staffing constraints threatening organic growth and the risk that technology-segment softness becomes margin dilutive. Valuation multiples offer some support: PE at 8.2x and EV/EBITDA at 6.6x are both modest for the sector, and both have eased lower over the past 30 days as the stock recovered less than the underlying earnings estimates implied. The forward EPS growth score ranks in the 71st percentile of the universe, a standout in an otherwise middling factor profile where EPS momentum scores are weak (22nd percentile on 30-day, 29th on 90-day).
Among close peers, the week's move was broadly positive but KBR's 6.2% gain lagged PSN (+10.1%) and CACI (+8.8%) while edging out J (+5.2%) and SAIC (+0.6%). The relative underperformance versus some government-services peers is worth watching given those names share similar federal spending exposure.
The prior two earnings prints offer a useful frame: on May 5 the stock dropped 9.2% on the day and extended to a 17% five-day loss — a sharp negative reaction. The more recent May 14 print produced only a 1.4% drop on the day before recovering 5.2% over the following week. With the stock having rebounded from insider-bought levels and analysts broadly above current prices, the July 29 print is less about whether KBR can grow and more about whether management can demonstrate that the staffing constraints flagged by bears are easing rather than worsening.
See the live data behind this article on ORTEX.
Open KBR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
